Tests were also used for increasing adherence, by showing that patients can have some control over their disease.
Improving discharge communication for parents and children in an emergency practice setting presents a significant opportunity for increasing adherence to treatment plans and improving health outcomes for children.
To date, trials have yielded mixed results regarding the efficacy of DAART for increasing adherence and viral suppression rates compared to self-administered therapy (SAT).
The primary aim of the study was to explore the efficacy of MI-CBT counseling combined with mDOT as compared to MI-CBT counseling alone or SC for increasing adherence to ART.
Collective efforts for increasing adherence to the CONSORT statement and STRICTA guidelines during design, implementation and reporting of clinical trials are needed to improve the completeness of reporting in Korean RCTs of acupuncture.
Given ACT's ability to address core theoretical processes proposed to contribute to behavior change, ACT appears to be particularly promising for increasing adherence to low-risk lifestyles among cardiac patients (e.g., low fat diet, smoking cessation, medication adherence)—a fundamental, but difficult goal to be attained.
Given the scarce resources available for increasing adherence, the concept of segmentation for health education based on health beliefs has the potential to identify those patients who will benefit most from additional counseling and reinforcement of the benefits from a given treatment plan.
This paper reports findings from a three arm, randomized controlled trial that examined whether MI-CBT counseling combined with mDOT (MI-CBT/mDOT) is more effective than counseling alone (MI-CBT) or standard care (SC) for increasing adherence to ART over 48 weeks among HIV-positive community clinic patients.
The primary objective of our trial is to determine whether modified DOT (mDOT) with both pegylated interferon alfa-2a plus ribavirin is more efficacious for increasing adherence and improving HCV treatment outcomes than treatment as usual (TAU), which includes weekly provider-administered pegylated interferon and self-administered ribavirin.
This pattern of increased adherence for LIS beneficiaries is not seen across all studies, as a recent analysis of a large Medicare cohort found that these individuals had lower adherence than a non-LIS comparison group, although this analysis did not control for comorbid conditions [ 24].
